Summary
To study the role and mechanisms of hypoxia-inducible factor-1alpha (HIF-1α) on the growth and tumorigenicity of lung cancer cells A549, the antisense oligonucleotide of HIF-1α was transfected to A549 cells. The effect of the antisense oligonucleotide on tumor growth in vitro and in vivo was evaluated by the growth rate suppression of A549 cells and subcutaneous implanted tumor in nude mice, and the effect on tumorigenicity was evaluated by the expression inhibition of angiogenic factors, the microvessel density (MVD) and vascular endothelial growth factor (VEGF) protein expression which were detected by immohistochemistry and western blot respectively. This study revealed that in vitro the growth rate of antisense oligonucleotide group was significantly decreased as compared with that of control group, sense oligonucleotide group and false-sense oligonucleotide group; in vivo the weight of implanted tumors in nude mice of antisense oligonucleotide group was 1.51±0.40 g, which was significantly lower than that of control group (2.79±0.33 g), sense oligonucleotide group (2.81±0.45g) and false-sense oligonucleotide group (2.89±0.39 g) and the inhibitory rate was 47 %. Both MVD and VEGF protein expression were significantly inhibited in antisense oligonucleotide group compared with those in other groups. These results indicated that antisense oligonucleotide of HIF-1α could inhibit lung cancer cells A549 growth in vitro and in vivo, and the mechanism may be due to the inhibition of vascular growth and VEGF protein expression.
Similar content being viewed by others
References
Wenger R H, Gassmann M. Oxygen and the hypoxia-inducible factor-1. Biol Chem, 1997, 378(7): 609–616
Graeber TG, Osmanian C, Jacks T et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 1996, 379(6560): 88–91
Dameron K M, Volpert O V, Tainsky MA et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 1994,265(5178):1582–1584
Mukhopadhyay D, Tsiokas L, Sukhatme V P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res, 1995,55(24):6161–6165
Ikeda E. Cellular response to tissue hypoxia and its involvement in disease progression. Pathol Int, 2005,55:603–610
Belozerov V E, Van Meir E G. Hypoxia inducible factor-1: a novel target for cancer therapy. Anticancer Drugs, 2005, 16:901–909
Gardner L B, Li Q, Park MS et al. Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem, 2001,276(11):7919–7926
Liu J R, Chen B Q, Yang YM et al. Effect of apoptosis on gastric adenocarcinoma cell line SGC-7901 induced by cis-9, trans-11-conjugated linoleic acid. World J Gastroenterol, 2002,8(6): 999–1004
Maxwell P H, Dachs G U, Gleadle J M et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA, 1997,94(15): 8104–8109
Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol, 1993,10(4): 302–313
Zhong H, De Marzo A M, Laughner E et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 1999,59(22): 5830–5835
Carmeliet P, Dor Y, Herbert J M et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 1998,394(6692):485–490
Ryan H E, Lo J, Johnson R S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J, 1998,17(11): 3005–3015
Author information
Authors and Affiliations
Additional information
ZHANG Wanguang, born in 1972, Doctor in Charge
This project was supported by a grant from the National Natural Science Foundation of China (No. 30500224).
Rights and permissions
About this article
Cite this article
Zhang, W., Zhang, H. & Xing, L. Antisense oligonucleotide of hypoxia-inducible factor-1alpha suppresses growth and tumorigenicity of lung cancer cells A549. J. Huazhong Univ. Sc. Technol. 26, 448–450 (2006). https://doi.org/10.1007/s11596-006-0418-6
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-006-0418-6